Blood vessel abnormalities in the eye are a major factor in the progression of Alzheimer's disease, according to research from Cedars-Sinai investigators published in the journal Alzheimer's & Dementia. These changes correspond ...
May 19, 2023
0
57
A new research perspective was published in Oncotarget, titled "Disruption of retinol-mediated IL-6 expression in colon cancer-associated fibroblasts: new perspectives on the role of vitamin A metabolism."
May 3, 2023
0
2
A St. Michael's-led study has uncovered a way in which inflammation of the heart can prompt the production of a protein that impairs heart function.
May 2, 2023
0
28
A new editorial paper was published in Oncotarget's , titled "Tumor necroptosis promotes metastasis through modulating the interplay between tumor and host immunity."
Apr 24, 2023
0
5
A study led by University at Buffalo researchers has confirmed that contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots. In addition, the ...
Apr 14, 2023
0
20
A technique for measuring the cardiac risk associated with cobalt-containing hip replacements has been highlighted for the first time in research at the University of Strathclyde.
Apr 14, 2023
0
1
Antioxidants in the roselle plant have anti-obesity properties that could help in food alternatives to current weight management medications, according to new research.
Mar 7, 2023
0
3
Fetal alcohol exposure at any stage of pregnancy can lead to congenital malformations, as well as cognitive, behavioral, and emotional impairments in offspring. New research conducted in mice and published in The FASEB Journal ...
Mar 6, 2023
0
11
A new editorial paper was published in Oncotarget titled "Unveiling the non-canonical functions of EZH2 in prostate cancer."
Mar 3, 2023
0
3
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond ...
Mar 3, 2023
0
16
